Lunai Bioworks Inc. (LNAI) Scorecard
- 2026-Q2: Total return Lose; Revenue growth Lose; EPS growth Lose.
- 2026-Q1: Total return Lose; Revenue growth Lose; EPS growth Lose.
- 2025-Q4: Total return Lose; Revenue growth Lose; EPS growth Lose.
- 2025-Q3: Total return Lose; Revenue growth Lose; EPS growth Lose.
15/120
All 120 Win/Lose results shown below
Every strict quarterly win earns 1 point. A loss, tie, or unavailable scoring value earns 0.
Trailing 1 year (4 quarters): 0 wins, 12 lossesLast fetched: 4 Sept 2026
Complete point ledger
Each cell identifies the missing side explicitly.
| Quarter | Total return | Revenue growth | EPS growth |
|---|---|---|---|
| 2026-Q20/3 |
LoseLNAI / S&P 0.18% / 15.20% |
LoseLNAI / S&P LNAI unavailable / 15.00% |
LoseLNAI / S&P LNAI unavailable / 50.40% |
| 2026-Q10/3 |
LoseLNAI / S&P -53.74% / -4.33% |
LoseLNAI / S&P LNAI unavailable / 11.30% |
LoseLNAI / S&P -163.86% / 27.70% |
| 2025-Q40/3 |
LoseLNAI / S&P -37.89% / 2.65% |
LoseLNAI / S&P LNAI unavailable / 9.00% |
LoseLNAI / S&P -157.33% / 13.40% |
| 2025-Q30/3 |
LoseLNAI / S&P -50.87% / 8.12% |
LoseLNAI / S&P LNAI unavailable / 4.61% |
LoseLNAI / S&P -152.82% / 13.45% |
| 2025-Q21/3 |
LoseLNAI / S&P -46.78% / 10.94% |
LoseLNAI / S&P LNAI unavailable / 4.83% |
WinLNAI / S&P 48.00% / 10.63% |
| 2025-Q11/3 |
LoseLNAI / S&P -35.05% / -4.27% |
LoseLNAI / S&P LNAI unavailable / 4.98% |
WinLNAI / S&P 176.72% / 10.57% |
| 2024-Q42/3 |
WinLNAI / S&P 73.08% / 2.41% |
LoseLNAI / S&P LNAI unavailable / 5.25% |
WinLNAI / S&P 435.71% / 6.15% |
| 2024-Q31/3 |
LoseLNAI / S&P -72.40% / 5.89% |
LoseLNAI / S&P LNAI unavailable / 5.89% |
WinLNAI / S&P 374.65% / 6.11% |
| 2024-Q21/3 |
LoseLNAI / S&P -33.96% / 4.28% |
LoseLNAI / S&P LNAI unavailable / 5.38% |
WinLNAI / S&P 5.63% / 5.12% |
| 2024-Q10/3 |
LoseLNAI / S&P -16.40% / 10.56% |
LoseLNAI / S&P LNAI unavailable / 5.71% |
LoseLNAI / S&P LNAI unavailable / 5.59% |
| 2023-Q40/3 |
LoseLNAI / S&P -29.08% / 11.69% |
LoseLNAI / S&P LNAI unavailable / 6.81% |
LoseLNAI / S&P LNAI unavailable / 7.78% |
| 2023-Q31/3 |
WinLNAI / S&P 688.36% / -3.27% |
LoseLNAI / S&P LNAI unavailable / 7.52% |
LoseLNAI / S&P LNAI unavailable / -5.03% |
| 2023-Q20/3 |
LoseLNAI / S&P -38.03% / 8.74% |
LoseLNAI / S&P LNAI unavailable / 9.50% |
LoseLNAI / S&P LNAI unavailable / -8.57% |
| 2023-Q10/3 |
LoseLNAI / S&P -11.17% / 7.50% |
LoseLNAI / S&P LNAI unavailable / 10.77% |
LoseLNAI / S&P LNAI unavailable / -15.69% |
| 2022-Q40/3 |
LoseLNAI / S&P -43.09% / 7.56% |
LoseLNAI / S&P LNAI unavailable / 11.88% |
LoseLNAI / S&P LNAI unavailable / -17.99% |
| 2022-Q30/3 |
LoseLNAI / S&P -6.22% / -4.88% |
LoseLNAI / S&P LNAI unavailable / 13.47% |
LoseLNAI / S&P LNAI unavailable / -1.41% |
| 2022-Q20/3 |
LoseLNAI / S&P -76.61% / -16.10% |
LoseLNAI / S&P LNAI unavailable / 13.71% |
LoseLNAI / S&P LNAI unavailable / 11.04% |
| 2022-Q11/3 |
WinLNAI / S&P 13.17% / -4.60% |
LoseLNAI / S&P LNAI unavailable / 15.97% |
LoseLNAI / S&P LNAI unavailable / 42.23% |
| 2021-Q40/3 |
LoseLNAI / S&P 8.32% / 11.03% |
LoseLNAI / S&P LNAI unavailable / 15.00% |
LoseLNAI / S&P LNAI unavailable / 96.40% |
| 2021-Q31/3 |
WinLNAI / S&P 35.41% / 0.58% |
LoseLNAI / S&P LNAI unavailable / 10.77% |
LoseLNAI / S&P LNAI unavailable / 69.42% |
| 2021-Q21/3 |
WinLNAI / S&P 40.40% / 8.55% |
LoseLNAI / S&P LNAI unavailable / 6.58% |
LoseLNAI / S&P LNAI unavailable / 51.81% |
| 2021-Q11/3 |
WinLNAI / S&P 20.00% / 6.17% |
LoseLNAI / S&P LNAI unavailable / -1.06% |
LoseLNAI / S&P LNAI unavailable / 7.39% |
| 2020-Q40/3 |
LoseLNAI / S&P -17.60% / 12.15% |
LoseLNAI / S&P LNAI unavailable / -3.72% |
LoseLNAI / S&P LNAI unavailable / -33.42% |
| 2020-Q30/3 |
LoseLNAI / S&P -14.96% / 8.93% |
LoseLNAI / S&P LNAI unavailable / -2.04% |
LoseLNAI / S&P LNAI unavailable / -27.10% |
| 2020-Q21/3 |
WinLNAI / S&P 40.33% / 20.54% |
LoseLNAI / S&P LNAI unavailable / -0.46% |
LoseLNAI / S&P LNAI unavailable / -27.11% |
| 2020-Q10/3 |
LoseLNAI / S&P -40.24% / -19.60% |
LoseLNAI / S&P LNAI unavailable / 3.47% |
LoseLNAI / S&P LNAI unavailable / -14.75% |
| 2019-Q40/3 |
LoseLNAI / S&P -8.73% / 9.07% |
LoseLNAI / S&P LNAI unavailable / 5.36% |
LoseLNAI / S&P LNAI unavailable / 2.99% |
| 2019-Q31/3 |
WinLNAI / S&P 22.22% / 1.70% |
LoseLNAI / S&P LNAI unavailable / 5.02% |
LoseLNAI / S&P LNAI unavailable / 0.21% |
| 2019-Q20/3 |
LoseLNAI / S&P -35.16% / 4.30% |
LoseLNAI / S&P LNAI unavailable / 6.64% |
LoseLNAI / S&P LNAI unavailable / 8.65% |
| 2019-Q10/3 |
LoseLNAI / S&P -0.86% / 13.65% |
LoseLNAI / S&P LNAI unavailable / 8.12% |
LoseLNAI / S&P LNAI unavailable / 14.29% |
| 2018-Q41/3 |
WinLNAI / S&P 19.86% / -13.52% |
LoseLNAI / S&P LNAI unavailable / 9.05% |
LoseLNAI / S&P LNAI unavailable / 18.23% |
| 2018-Q31/3 |
WinLNAI / S&P 75.90% / 7.71% |
LoseLNAI / S&P LNAI unavailable / 10.21% |
LoseLNAI / S&P LNAI unavailable / 19.06% |
| 2018-Q20/3 |
LoseLNAI / S&P -39.64% / 3.43% |
LoseLNAI / S&P LNAI unavailable / 9.03% |
LoseLNAI / S&P LNAI unavailable / 14.46% |
| 2018-Q10/3 |
LoseLNAI / S&P LNAI unavailable / -0.76% |
LoseLNAI / S&P LNAI unavailable / 7.68% |
LoseLNAI / S&P LNAI unavailable / 12.46% |
| 2017-Q40/3 |
LoseLNAI / S&P LNAI unavailable / 6.64% |
LoseLNAI / S&P LNAI unavailable / 7.03% |
LoseLNAI / S&P LNAI unavailable / 13.82% |
| 2017-Q30/3 |
LoseLNAI / S&P LNAI unavailable / 4.48% |
LoseLNAI / S&P LNAI unavailable / 5.68% |
LoseLNAI / S&P LNAI unavailable / 17.57% |
| 2017-Q20/3 |
LoseLNAI / S&P LNAI unavailable / 3.09% |
LoseLNAI / S&P LNAI unavailable / 4.83% |
LoseLNAI / S&P LNAI unavailable / 17.74% |
| 2017-Q10/3 |
LoseLNAI / S&P LNAI unavailable / 6.07% |
LoseLNAI / S&P LNAI unavailable / 3.67% |
LoseLNAI / S&P LNAI unavailable / 13.32% |
| 2016-Q40/3 |
LoseLNAI / S&P LNAI unavailable / 3.82% |
LoseLNAI / S&P LNAI unavailable / 2.09% |
LoseLNAI / S&P LNAI unavailable / 7.05% |
| 2016-Q30/3 |
LoseLNAI / S&P LNAI unavailable / 3.85% |
LoseLNAI / S&P LNAI unavailable / 0.20% |
LoseLNAI / S&P LNAI unavailable / -3.15% |
Dividend-reinvested, split-adjusted total return
1Y · 2025-08-29 to 2026-08-27
| Metric | LNAI total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -87.66% | 20.78% |
| Annualized return | -87.66% | 20.78% |
5Y · 2021-09-01 to 2026-08-27
| Metric | LNAI total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -99.61% | 83.14% |
| Annualized return | -66.99% | 12.86% |
10Y · 2018-02-07 to 2026-08-27
| Metric | LNAI total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -99.50% | 319.30% |
| Annualized return | -41.15% | 15.41% |
Calculation rules
- window
- Latest 40 completed benchmark quarters; unavailable issuer evidence remains visible and scores 0.
- return Basis
- Issuer adjusted close reinvests distributions and normalizes splits; the S&P 500 Total Return Index is the direct benchmark.
- point Rule
- Strict same-quarter win = 1. Loss, tie or unavailable evidence = 0. No partial or subjective points.
- frequency
- Quarter endpoints only.
- fundamentals
- Trailing-four-quarter issuer revenue and EPS growth use the issuer's normalized government-filed facts.
- non Scoring
Snapshot captured 2026-09-04.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |
| TENAX THERAPEUTICS, INC. (TENX) | United States | $0.071B | -7.17 |
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| Verrica Pharmaceuticals Inc. (VRCA) | United States | $0.076B | -3.39 |